Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: Clinical Controversies

436 - Fidaxomicin isn't necessary with Vancomycin and Bezlotuxumab: Pro

Friday, October 18, 2024
3:15 PM – 3:33 PM US PT
Location: Concourse 152
Disclosure(s):
Kelly R. Reveles, PharmD, PhD, BCIDP: AstraZeneca: Grant/Research Support (Ongoing); Ferring Pharmaceuticals Inc.: Advisor/Consultant (Ongoing), Honoraria (Ongoing)